LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 208 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $980,000 | +357.9% | 6,348 | +311.7% | 0.00% | +100.0% |
| Q3 2021 | $214,000 | +5.9% | 1,542 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $202,000 | -15.5% | 1,542 | -1.8% | 0.00% | 0.0% |
| Q1 2021 | $239,000 | +2.6% | 1,571 | -35.8% | 0.00% | 0.0% |
| Q3 2020 | $233,000 | -11.7% | 2,448 | +3.5% | 0.00% | 0.0% |
| Q2 2020 | $264,000 | +21.7% | 2,365 | +13.2% | 0.00% | 0.0% |
| Q4 2019 | $217,000 | -16.2% | 2,090 | -19.8% | 0.00% | 0.0% |
| Q3 2019 | $259,000 | -54.7% | 2,605 | -48.0% | 0.00% | -66.7% |
| Q2 2019 | $572,000 | +18.4% | 5,011 | +30.3% | 0.00% | +50.0% |
| Q1 2019 | $483,000 | +10.3% | 3,847 | +141.0% | 0.00% | 0.0% |
| Q3 2018 | $438,000 | +101.8% | 1,596 | +52.3% | 0.00% | +100.0% |
| Q2 2018 | $217,000 | +9.0% | 1,048 | -13.3% | 0.00% | 0.0% |
| Q1 2018 | $199,000 | -2.9% | 1,209 | -19.2% | 0.00% | 0.0% |
| Q4 2017 | $205,000 | – | 1,497 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KNOTT DAVID M | 353,041 | $36,819,000 | 14.92% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 919,994 | $95,946,000 | 2.93% |
| Elk Creek Partners, LLC | 236,862 | $24,702,000 | 2.84% |
| Conestoga Capital Advisors, LLC | 619,653 | $64,624,000 | 1.56% |
| WOODSTOCK CORP | 71,489 | $7,456,000 | 1.21% |
| Summit Creek Advisors LLC | 70,962 | $7,401,000 | 1.16% |
| FALCON POINT CAPITAL, LLC | 8,115 | $846,000 | 1.08% |
| RICE HALL JAMES & ASSOCIATES, LLC | 302,503 | $31,548,000 | 1.07% |
| Stephens Investment Management Group LLC | 508,100 | $52,990,000 | 1.00% |
| Tygh Capital Management, Inc. | 55,672 | $5,806,000 | 0.96% |